In this in vitro model, ADSCs treated with SSc serum showed reduced adipogenic markers (like perilipin and adiponectin) and upregulated myofibroblast markers (including α-SMA, S100A4, and type I collagen). The gene discussed is ACTA1; the disease is systemic sclerosis.